Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

EPS of $3.91, or 4.3% growth from the midpoint of 2023 earnings guidanceIncreasing five-year capital forecast by 10% to $4.7 ...

Net Interest Income increased $3.4 million, or 3.8%, to $91.8 million for the year ended December 31, 2024, from $88.4 million for the year ended ...

Reports Q4 revenue $68.11M vs. $42.4M last year. “In Q4, we surpassed revenue expectations highlighting our market diversification, and entered ...

During the second quarter we continued to generate strong operating cash flow while reducing debt levels, effectively reaching our fiscal ...

M, consensus $661.18M.Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' Smart Score, ...

Reports Q4 revenue $637M, consensus $634.59M. “As we enter 2025, we believe that our targeted investments in product innovation and sales ...

EST Franklin Resources (BEN) files automatic mixed securities shelfMaximize Your Portfolio with Data Driven Insights:Leverage the power ...

Inseego (INSG) announced that Phil Brace is stepping down from his role as executive chairman of the company’s board, effective immediately, in ...

Fourth quarter comparable store sales growth of 4.4%, full-year increase of 2.9%$3.0 billion net cash provided by operating activities in ...

Reports Q4 revenue $597.1M vs. $591.7M last year. “We advanced our regulatory and growth initiatives and delivered strong earnings,” said Linn ...

As we roll forward our five-year plan, I’m confident in our 4% to 6% long-term EPS growth target given our customer-focused capital outlook ...